STOCK TITAN

HeartSciences (HSCS) Revenue by Year

HSCS NASDAQ

HeartSciences Inc. generated $4K in revenue in fiscal year 2026. This represents a decrease of 0.7% from the prior fiscal year. Over the trailing 12 months, Q2 FY2026 through Q1 FY2027, the same line adds up to $5K in revenue. The table below carries 5 fiscal years, from 2022 to 2026, and the quarters HeartSciences Inc. has filed alongside them.

FY2026 annual
Revenue $4K
YoY -0.7%
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2027, ended Jul 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

HSCS Revenue by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2610-KFY2510-KFY2410-KFY2310-KFY2210-K
Revenue$5K$4K-0.7%$4K-76.6%$19K+261.2%$5K-64.2%$14K

TTM is the trailing twelve months, Q2 FY2026 through Q1 FY2027, summed from the four most recent quarterly filings.

HSCS Revenue by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2710-QQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-Q
Revenue$2K+10.5%$0$0n/m$2K$2KN/A$0-100.0%N/AN/AN/A$15K+653.8%$4K

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More HeartSciences Inc. financials

Frequently Asked Questions

HeartSciences Inc. generated $4K in revenue in fiscal year 2026.

HeartSciences Inc. (HSCS) revenue fell by 0.7% year over year, from $4K to $4K in fiscal year 2026.

HeartSciences Inc. (HSCS) reported $5K in revenue over the trailing 12 months, Q2 FY2026 through Q1 FY2027, summed from the four most recent quarterly filings.

Across the 5 fiscal years this page covers, HeartSciences Inc. (HSCS) revenue went from $14K in fiscal year 2022 to $4K in fiscal year 2026.

HeartSciences Inc. (HSCS) reported $2K in revenue in Q1 2027. This represents an increase of 10.5% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what HeartSciences Inc. (HSCS) reported on that line in every period on record.